本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

46.51
-0.2300-0.49%
盤後46.510.00000.00%19:39 EDT
成交量:213.92萬
成交額:9,998.02萬
市值:88.31億
市盈率:-13.16
高:47.36
開:47.05
低:46.14
收:46.74
資料載入中...
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/09

重要事件披露

Form 8-K - Current report
2024/01/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/25

重要事件披露

Form 8-K - Current report
2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]